Current Approaches to Epigenetic Therapy.

IF 2.5 Q3 GENETICS & HEREDITY
Ekaterina D Griazeva, Daria M Fedoseeva, Elizaveta I Radion, Pavel V Ershov, Ivan O Meshkov, Alexandra V Semyanihina, Anna S Makarova, Valentin V Makarov, Vladimir S Yudin, Anton A Keskinov, Sergey A Kraevoy
{"title":"Current Approaches to Epigenetic Therapy.","authors":"Ekaterina D Griazeva,&nbsp;Daria M Fedoseeva,&nbsp;Elizaveta I Radion,&nbsp;Pavel V Ershov,&nbsp;Ivan O Meshkov,&nbsp;Alexandra V Semyanihina,&nbsp;Anna S Makarova,&nbsp;Valentin V Makarov,&nbsp;Vladimir S Yudin,&nbsp;Anton A Keskinov,&nbsp;Sergey A Kraevoy","doi":"10.3390/epigenomes7040023","DOIUrl":null,"url":null,"abstract":"<p><p>Epigenetic therapy is a promising tool for the treatment of a wide range of diseases. Several fundamental epigenetic approaches have been proposed. Firstly, the use of small molecules as epigenetic effectors, as the most developed pharmacological method, has contributed to the introduction of a number of drugs into clinical practice. Secondly, various innovative epigenetic approaches based on dCas9 and the use of small non-coding RNAs as therapeutic agents are also under extensive research. In this review, we present the current state of research in the field of epigenetic therapy, considering the prospects for its application and possible limitations.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"7 4","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594535/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epigenomes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/epigenomes7040023","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Epigenetic therapy is a promising tool for the treatment of a wide range of diseases. Several fundamental epigenetic approaches have been proposed. Firstly, the use of small molecules as epigenetic effectors, as the most developed pharmacological method, has contributed to the introduction of a number of drugs into clinical practice. Secondly, various innovative epigenetic approaches based on dCas9 and the use of small non-coding RNAs as therapeutic agents are also under extensive research. In this review, we present the current state of research in the field of epigenetic therapy, considering the prospects for its application and possible limitations.

Abstract Image

Abstract Image

表观遗传学治疗的最新方法。
表观遗传学治疗是治疗多种疾病的一种很有前途的工具。已经提出了几种基本的表观遗传学方法。首先,使用小分子作为表观遗传学效应物,作为最发达的药理学方法,有助于将许多药物引入临床实践。其次,基于dCas9的各种创新表观遗传学方法以及使用小型非编码RNA作为治疗剂也在广泛研究中。在这篇综述中,我们介绍了表观遗传学治疗领域的研究现状,并考虑了其应用前景和可能的局限性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Epigenomes
Epigenomes GENETICS & HEREDITY-
CiteScore
3.80
自引率
0.00%
发文量
38
审稿时长
11 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信